Allergan Operating Metrics

Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.

Allergan key operating metrics including Key Promoted Products, environmental, and social and governance score (ESG).

Key Promoted Products

5.9%

FY, 2019

Administration Facilities

FY, 2019

Countries

100

Q1, 2020

Operating Metrics

Metrics	FY, 2016	FY, 2017	FY, 2018	FY, 2019
Key Promoted Products	36	25	17	18
Administration Facilities	6	5	4	4
Countries	100	100	100	100
R&D Facilities	1	2	4	4
Manufacturing Facilities	10	14	13	13
Facilities	17	21	21	21
Facilities Leased	7	11	11	11
Facilities Owned	11	11	10	10
Phase II Trials Products (Eye Care)		2	2	2
Phase III Trials Products (Eye Care)		2	3	1
Phase III Trials Products (Neuroscience)		3	3	1
Filed Trials Products (Neuroscience)		1	1
Phase II Trials Products (Medical Aesthetics)		2	1	1
Phase II Trials Products (Gastrointestinal)		1	2
Phase III Trials Products (Gastrointestinal)		2	2	2
Filed Trials Products (Eye Care)				2

40-49 out of 100

Community

Employees

Environment

Governance

Premium Content only available in Craft’s Intelligence Portal

Source:CSRHub